 |
Xilio Therapeutics
Last updated: January 16, 2024
Simon Tomlinson - CEO
Country: USA | Funding: $233M (+)
Website: https://akriveiatx.com/
Xilio Therapeutics is a biopharmaceutical company focused on developing highly-potent, targeted immuno-oncology therapeutics.
Website: https://akriveiatx.com/
Xilio Therapeutics is a biopharmaceutical company focused on developing highly-potent, targeted immuno-oncology therapeutics.
